posted on 1997-02-14, 00:00authored byIvan I. Fedorov, Ema M. Kazmina, Galina V. Gurskaya, Maxim V. Jasko, Valery E. Zavodnic, Jan Balzarini, Erik De Clercq, Abdesslem Faraj, Jean-Pierre Sommadossi, Jean-Louis Imbach, Gilles Gosselin
A synthetic scheme for the 3‘-oxime derivatives 3E,
5E, 5Z, 7E and 7Z of
1-(2,3-dideoxy-β-d-glycero-pentofuranosyl)thymine and for
1-(2,3-dideoxy-3-nitro-β-d-erythro-pentofuranosyl)thymine (10) has been developed starting from appropriately
5‘-protected 3‘-ketothymidine.
X-ray analysis showed that 3‘-N-hydroxyimino
3E and 3‘-N-methoxyimino 5Z
derivatives have
close molecular conformations: anti about the N1−C1‘
bond, and gauche+ about the
C4‘−C5‘
exocyclic bond. Their sugar conformations are
C1‘-exo−O4‘-endo and
C1‘-exo−C2‘-endo,
respectively. The antiviral assays in cell cultures demonstrated
that 3‘-N-hydroxyimino 3E
and 3‘-N-acetoxyimino 7E + 7Z derivatives are
endowed with significant activity against human
immunodeficiency virus (HIV) with EC50 values ranging
between 0.02 and 0.40 μg/mL for both
HIV-1 and HIV-2. The other compounds 5E + 5Z and
10 were at least 2 orders of magnitude less active. The 3‘-N-hydroxyimino derivative
3E also shows promising activity against
hepatitis B virus (HBV) (EC50 = 0.25 μg/mL) and against
herpes simplex virus type 1 (HSV-1)
and HSV-2.